Ellie Im
Chief Tech/Sci/R&D Officer bei CENTESSA PHARMACEUTICALS PLC
Profil
Ellie Im is currently a Member at the American Society of Clinical Oncology, Inc. and a Senior VP-Oncology Clinical Development at Centessa Pharmaceuticals Plc.
Previously, Dr. Im worked as a Medical Director at Merck & Co., Inc., a Senior Director-Medical at Tesaro, Inc., and a Senior VP-Clinical Development & Operation at Mersana Therapeutics, Inc. Dr. Im holds a doctorate degree from the Catholic University of Korea School of Medicine.
Aktive Positionen von Ellie Im
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 03.10.2023 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ellie Im
| Unternehmen | Position | Ende |
|---|---|---|
| TESARO INC | Chief Tech/Sci/R&D Officer | - |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | - |
| MERSANA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MERSANA THERAPEUTICS, INC. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
